TCThayná Laner Cardoso

Thayná Laner Cardoso

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thayná Laner Cardoso has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biogenic Silver Nanoparticles: An Antibacterial and Antibiofilm Approach to Control Carbapenem-Resistant Klebsiella pneumoniae

    by Daniela Rodriguero Wozeak, Isabel Ladeira Pereira, Thayná Laner Cardoso, Luciano Aparecido Panagio, Gerson Nakazato, Izani Bonel Acosta, Antonio Sergio Varela, Daiane Drawanz Hartwig

    The increasing resistance of Klebsiella pneumoniae to antibiotics, particularly carbapenems, underscores the urgent need for alternative antimicrobial strategies. This study aimed to evaluate the antimicrobial and antibiofilm activity of biogenic silver nanoparticles (Bio-AgNPs), synthesized using Trichilia catigua extract and to investigate their mechanism of action on bacterial cells. The antimicrobial efficacy of Bio-AgNPs was assessed by determining the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and through susceptibility assays, time-kill analysis, flow cytometry, and electron microscopy. Bio-AgNPs exhibited strong antibacterial activity against all tested K. pneumoniae strains, with MICs ranging from 0.49 to 15.62 µg/mL. Eradication of biofilms required concentrations 16 to 64 times higher than those effective against planktonic cells, highlighting the protective nature of biofilm matrix. Time-kill assays showed a concentration-dependent bactericidal effect, with 4xMIC rapidly eliminating viable cells. Flow cytometry indicated membrane destabilization, increased fluidity at lower concentrations, and extensive structural damage at higher concentrations. Although lipid peroxidation and reactive oxygen species (ROS) were detected, they were not statistically significant, suggesting that membrane disruption is the primary bactericidal mechanism. Electron microscopy corroborated the structural disintegration of both bacterial cells and biofilms after treatment. Bio-AgNPs demonstrated potent antimicrobial and antibiofilm effects against multidrug-resistant K. pneumoniae , with membrane damage as the main mechanism of action. These results support the potential application of Bio-AgNPs as a therapeutic alternative for biofilm-associated infections. This study highlights the antibacterial and anti-biofilm potential of biogenic silver nanoparticles (Bio-AgNPs) as an effective tool against multidrug-resistant Klebsiella pneumoniae , with efficancy against both free-living cells and structured biofilms.


  • Advances in ELISA-based detection of equine leptospirosis

    by Thayná Laner Cardoso, Daniela Rodriguero Wozeak, Isabel Ladeira Pereira, Laura Dias da Silva Ribeiro, Rogério Oliveira Rodrigues, Daiane Drawanz Hartwig


  • A promising approach to control carbapenem-resistant Acinetobacter baumannii: Investigating immune pathways through rFilF immunization

    by Isabel Ladeira Pereira, Daniela Rodriguero Wozeak, Antônio Duarte Pagano, Thayná Laner Cardoso, Izani Bonel Acosta, Antonio Sergio Varela Junior, Geferson Fischer, Vinicius Farias Campos, Daiane Drawanz Hartwig


  • Chimeric recombinant protein (rErpY-LemA) as innovative tools for animal leptospirosis serodiagnosis

    by Thayná Laner Cardoso, Daniela Rodriguero Wozeak, Isabel Ladeira Pereira, Natali Lima Dias, Amilton Clair Pinto Seixas Neto, Rogerio Oliveira Rodrigues, Daiane Drawanz Hartwig


  • Genetic diversity, drug resistance, and biofilm formation in Klebsiella pneumoniae associated with nosocomial infection in Pelotas, RS, Brazil

    by Daniela R. Wozeak, Isabel L. Pereira, Thayná L. Cardoso, Amilton C. P. S. Neto, Daiane D. Hartwig

    Antibiotic resistance and the potential persistence of Klebsiella pneumoniae strains in hospital environments is an important challenge for human medicine. This research aims to detect resistance to antibiotics, biofilm formation, and the genetic pattern among clinical isolates associated with nosocomial infection obtained from a university hospital in the city of Pelotas, RS, Brazil. Twenty-eight isolates were identified at the species level by polymerase chain reaction (PCR) and were characterized regarding the profile of biofilm formation and antibiotic resistance. The genetic relationship was determined through pulsed-field gel electrophoresis (PFGE). The antibiotic resistance profile was made following the standards established by CLSI. All clinical isolates included in this study were confirmed as belonging to the species K. pneumoniae, 96.42% were considered strong biofilm formers and all were positive in the Congo Red agar (CRA) test. Thus, 64.29% of isolates were classified as multidrug-resistant (MDR), 25% as extensively drug-resistant (XDR), and 7.14% as pandrug-resistant (PDR). PFGE fingerprint analysis revealed 18 clones and of these, 15 have a unique pattern and another three were groups with patterns > 80% similarity. The clinical isolates used were collected over two years and revealed a genetic relationship. The same clone was identified in different types of samples and different years, demonstrating the permanence of the strain in the hospital environment. Our results reaffirm the need for greater measures of control and disinfection within the hospital environment, and the priority of therapeutic measures to contain the propagation of K. pneumoniae.


  • Advancing serologic diagnosis: assessing the efficacy of rErpY-like protein in human leptospirosis detection

    by Thayná Laner Cardoso, Stella Buchhorn de Freitas, Amilton Clair Pinto Seixas Neto, Ilana Teruszkin Balassiano, Daiane Drawanz Hartwig

    Leptospirosis is a globally distributed infectious disease caused by pathogenic spirochetes of the Leptospira genus, often overlooked. It is estimated that the disease affects approximately one million people annually, resulting in more than 58,900 deaths. The gold standard for serodiagnosis of leptospirosis is the Microscopic Agglutination Test (MAT). However, the limitations of this technique necessitate the exploration of alternative diagnostic methods. In this study, we evaluated the ErpY-like recombinant protein (rErpY-like) in the development of a serologic diagnostic assay for human leptospirosis. Eighty-six human sera samples, characterized by MAT, underwent evaluation through indirect IgM-ELISA and IgG-ELISA. The sensitivity and specificity values obtained from IgM-ELISA were 60% and 76%, respectively, while those from IgG-ELISA were 96.4% and 100%, respectively. The use of the rErpY-like protein in both IgM-ELISA and IgG-ELISA proves to be a sensitive and specific method for antibody detection. This could potentially serve as a valuable alternative tool in the diagnosis of human leptospirosis.